EXPERIMENTAL STUDY OF FUFANGBIEJIARUANGANFANG DRUG SERUM ON THE EXPRESSION OF TGF-β TYPE Ⅰ RECEPTOR AND Smad-3 PROTEIN IN RAT HSCs

Acta Anatomica Sinica ›› 2008, Vol. 39 ›› Issue (2) : 180-186.

Welcome to visit Acta Anatomica Sinica! Today is Chinese
Acta Anatomica Sinica ›› 2008, Vol. 39 ›› Issue (2) : 180-186.
论著

EXPERIMENTAL STUDY OF FUFANGBIEJIARUANGANFANG DRUG SERUM ON THE EXPRESSION OF TGF-β TYPE Ⅰ RECEPTOR AND Smad-3 PROTEIN IN RAT HSCs

Author information +
History +

Abstract

Objective To investigate the effect of fufangbiejiaruanganfang drug serum on the expression of TGF-β type I receptor and Smad-3 protein in rat hepatic stellate cells(HSCs). Methods Immunocytochemical staining and image analysis were applied to investigate the effect of different dosages of fufangbiejiaruanganfang drug serums on the expression of TGF-β type I receptor and Smad-3 protein in rat HSCs. Results High and medium dosage of fufangbiejiaruanganfang drug serum remarkably downregulated the expression of TGF-β type I receptor and Smad-3 protein in rat HSCs in a dosedependent manner. Conclusion The experiment demonstrated that fufangbiejiaruanganfang drug serums can downregulate the expression of TGF-β type I receptor and Smad-3 protein in HSCs and further inhibit the activation of HSCs and improve liver fibrosis. So the downregulation of TGF-β type I receptor in HSCs may be one of

Key words

Fufangbiejiaruanganfang / Hepatic stellate cell (HSCs) / Transforming growth factorβ1(TGF-β1) / Smad-3 protein / Immunohisochemistry / Rat

Cite this article

Download Citations
EXPERIMENTAL STUDY OF FUFANGBIEJIARUANGANFANG DRUG SERUM ON THE EXPRESSION OF TGF-β TYPE Ⅰ RECEPTOR AND Smad-3 PROTEIN IN RAT HSCs[J]. Acta Anatomica Sinica. 2008, 39(2): 180-186

Accesses

Citation

Detail

Sections
Recommended

/